mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.06 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.06 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.06 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.07 |
mRNA |
Bortezomib |
GDSC1000 |
pan-cancer |
AAC |
0.087 |
0.07 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.07 |
mRNA |
CGP-60474 |
GDSC1000 |
pan-cancer |
AAC |
0.091 |
0.07 |
mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.07 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.07 |
mRNA |
JW-7-24-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.053 |
0.07 |